Advertisement

Regulation of Glycosphingolipid Anabolism in Fibroblasts by Ionophores, Plasma Membrane ATP-ase Inhibition, and Growth Factors

  • Mariko Saito
  • Abraham Rosenberg
Part of the NATO ASI Series book series (NSSA, volume 116)

Abstract

We have undertaken studies on the effects of a monovalent cation transporter (monensin) on the anabolism of plasma membrane glycosphingolipids in human fibroblasts, and made comparisons with related (cat)ionophores, and with epidermal growth factor (EGF) and phorbol 12-myristate 13-acetate (PMA). Monensin at a concentration of 10 nanomoles per litre of growth medium caused a great increase in the cellular content of glucosyl and lactosyl ceramide, and marked inhibition of incorporation of labelled galactose into ganglio-sides as well as globotriaosyl- and globotetraosyl ceramides. The plasma membrane sodium-potassium ion ATP-ase inhibitor, ouabain, and the calcium ionophore, A23187, had an effect similar to monensin although less effective. TMB-8, an intracellular calcium antagonist, induced an increase in [3H]Gal incorporation, after epimerization, into glucosyl ceramide. Cyclic AMP had no significant effect on these glycosphingolipids or on the changes induced by monensin. PMA induced a higher incorporation of labelled galactose into almost all glycosphingolipids; EGF showed no effect. Ionic flux should influence the anabolic composition of plasma membrane glycosphingolipids, and this effect may be independent from that of mitogenic growth factors.

Keywords

Epidermal Growth Factor Dibutyryl cAMP Sphingolipid Synthesis Cellular cAMP Level Mitogenic Growth Factor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Tartakoff, A. (1983) Cell 32, 1026–1028.PubMedCrossRefGoogle Scholar
  2. 2.
    Roseman, S. (1970) Chem. Phys. Lipids 5, 270–298.Google Scholar
  3. 3.
    Li, Y.-T. Li, S.-C. (1982) Adv. Carbohydr. Chem. Biochem. 40, 235–286.PubMedCrossRefGoogle Scholar
  4. 4.
    Basu, S. Basu, M. (1982) in The Glycoconjugates (Horwitz, M., Ed) Vol. III, pp 265–285, Academic Press, London.Google Scholar
  5. 5.
    Kishimoto, Y. (1982) in The Enzymes (Boyer, P.D., Ed) Vol. 16, pp 358407, Academic Press, New York.Google Scholar
  6. 6.
    Ledeen, R.W. (1983) in Handbook of Neurochemistry (Lajtha, A., Ed) Vol. 3 pp 41–90, Plenum Press, New York and London.Google Scholar
  7. 7.
    Saito, M., Saito, M. Rosenberg, A. (1984) Biochemistry 23, 1043–1046.PubMedCrossRefGoogle Scholar
  8. 8.
    Saito, M., Saito, M. Rosenberg, A. (1985) Biochemistry 24, 3054–3059.PubMedCrossRefGoogle Scholar
  9. 9.
    Irwin, C.C. Irwin, L.N. (1979) Anal. Biochem. 99, 335–339.CrossRefGoogle Scholar
  10. 10.
    Saito, M. Rosenberg, A. (1982) J. Lipid Res. 23, 3–8.PubMedGoogle Scholar
  11. 11.
    Kuske, T.T. Rosenberg, A. (1972) J. Lab Clin. Med. 80, 523–529.PubMedGoogle Scholar
  12. 12.
    Momoi, T., Ando, S. Nagai, Y. (1976) Biochem. Biophys. Acta 441, 479–488Google Scholar
  13. 13.
    Saito, M. Rosenberg, A. (1985) J. Biol. Chem. 260, 2295–2300.PubMedGoogle Scholar
  14. 14.
    Whetsell, Jr., W.O. Bunge, R.P. (1969) J. Cell. Biol. 42, 490–500.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1986

Authors and Affiliations

  • Mariko Saito
    • 1
  • Abraham Rosenberg
    • 1
  1. 1.Loyola University Medical CenterMaywoodUSA

Personalised recommendations